A traditional smoking cessation method in Spain has proven ineffective, prompting a group of 170 international experts to issue a letter urging Spanish authorities to change tactics and embrace reducing tobacco harm.
Royal Decree 579/2017 is legislation regarding the manufacturing, advertising, and sales of electronic cigarettes in Spain. Essentially, the decree transforms the strict Tobacco Products Directive (TPD) into Spanish regulations, and has been in effect since June 11, 2017.
Furthermore, the Spanish government has recently started to further restrict the sales and distribution of electronic cigarettes. The Ministry of Health has stated that they aim to revise local anti-smoking legislation and extend it to the use of e-cigarettes, as they can have "harmful short-term effects." Unfortunately, this approach is failing, as approximately one-third of Spanish adults still smoke.
Therefore, 170 international experts have jointly signed a letter calling for a change in strategy in Spain. The letter is targeting the Spanish authorities and is appealing for support of smoke-free products such as e-cigarettes, nicotine pouches, and heated tobacco products to reduce the harm caused by tobacco.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
